High Quality CAS 100986-85-4 Levofloxacin Hydrochloride with low price

Details:

Basic information

Levofloxacin, one of the quinolone drugs, has a broad-spectrum antibacterial effect. Strong antibacterial effect, against most Enterobacteriaceae bacteria, such as Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Haemophilus influenzae, Legionella pneumophila, Neisseria gonorrhoeae Such gram-negative bacteria have strong antibacterial activity; it also has antibacterial effects on gram-positive bacteria such as Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, Mycoplasma pneumoniae and Chlamydia pneumoniae, but it has antibacterial effects on anaerobic bacteria and enterococcus. The effect is poor.

Application
Applicable to those caused by sensitive bacteria:
1. Urogenital infections, including simple, complicated urinary tract infections, bacterial prostatitis, Neisseria gonorrhoeae urethritis.
2. Respiratory tract infections, including acute onset of bronchial infections caused by sensitive gram-negative bacilli and lung infections.
3. Gastrointestinal infections are caused by Shigella, Salmonella, Enterotoxigenic Escherichia coli, Hydrophilic Aeromonas, Vibrio parahaemolyticus, etc.
4. Typhoid fever.
5. Bone and joint infections.
6. Skin and soft tissue infections.
7. Systemic infections such as sepsis.
8. Chronic bronchitis.
Levofloxacin was launched in Japan in 1993. The drug has achieved good results in the treatment of respiratory tract infections, urogenital infections and skin and soft tissue infections. Among them, the effective rate and bacterial clearance rate for treating acute and chronic lower respiratory tract infections are 80% to 100%, and the clearance rate for Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus and pneumococcus is high, while for Pseudomonas aeruginosa The elimination of bacilli is poor. The effective rate and bacterial clearance rate for complex and simple urinary tract infections are also 80% to 100%. The effective rate of treating skin and soft tissue infections is 80%~91%, and the clearance rate of methicillin-sensitive Staphylococcus is close to 90%. The effective rate of treatment of obstetrics and gynecology, ear, nose, throat and other infections is also around 90%.
Staphylococcus, Pneumococcus, Streptococcus pyogenes, Streptococcus hemolyticus, Enterococcus, Peptic Streptococcus, Neisseria gonorrhoeae, Catalina Brahanella, Propionibacterium acnes, Escherichia coli, Citrobacter , Salmonella (except Typhoid and Paratyphoid), Shigella, Klebsiella, Enterobacter, Serratia, Proteus, Vibrio cholerae, Pseudomonas aeruginosa, Influenza Among Haemophilus, Acinetobacter, Campylobacter, and Chlamydia trachomatis, the following infections are caused by bacteria that are sensitive to this agent.
-Pneumonia, chronic bronchitis, diffuse bronchiolitis, bronchiectasis (when infected), secondary infections of chronic respiratory diseases.
-Pharyngitis, tonsillitis (peritonsilitis, peritonsilar abscess) acute bronchitis-pyelonephritis, cystitis, prostatitis, paradichitis, gonococcal urethritis, non-gonococcal urethritis.
-Intrauterine infection, cervicitis, adnexitis, bartholinitis.
-Folliculitis (including impetigo acne), furuncle, furunculosis, carbuncle contagious impetigo, erysipelas, cellulitis, lymphatic (nodular) inflammation, suppurative perithyroiditis (including gangrene), subcutaneous abscess , Hidradenitis, clustered acne, infectious powder tumor, perianal abscess.
-Secondary infections such as mastitis, trauma, burns and surgical wounds (superficial).
-Cholecystitis, cholangitis.
-Otitis externa, otitis media, paranasal sinusitis, suppurative, salivitis.
-Blepharitis, sty, dacryocystitis, conjunctivitis, meibomitis.
-Bacterial blood dysentery, infectious enteritis, salmonella enteritis, cholera.
-Periodontal tissue inflammation, peri-crown inflammation, jaw inflammation.

Packaging & Delivery